CervIcal Cancer Screening Trial by Randomization of HPV Testing Intervention for Upcoming Screening （CITRUS Study）
The aim of this study is to assess efficacy of the screening with concurrent liquid-based cytology and HPV DNA testing for the primary cervical cancer screening over 7 years.
Cervical Cancer
OTHER: LBC|OTHER: LBC plus HPV DNA testing
The incidence of cervical intraepithelial neoplasia(CIN)3 or worse during the whole period, 6 years
The incidence of CIN3 or worse at baseline, and two years, four years, and six years post baseline, 2 years, 4 years, 6 years|The incidence of CIN2 or worse at baseline, and two years, four years, and six years post baseline, 2 years, 4 years, 6 years|The incidence of CIN1 or worse at baseline, and two years, four years, and six years post baseline, 2 years, 4 years, 6 years|The incidence of invasive cancer at baseline, and two years, four years, and six years post baseline, 2 years, 4 years, 6 years|The number of cervical cytology performance, 6 years|The number of colposcopy and biopsy performance, 6 years
The aim of this study is to assess efficacy of the screening with concurrent liquid-based cytology and HPV DNA testing for the primary cervical cancer screening over 7 years.